Skip to main content
Premium Trial:

Request an Annual Quote

McDonald to Teach New Tricks at SBI


Structural Bioinformatics has taken a big step toward its goal of getting to discovery: the firm hired Ian McDonald, Merck’s former senior director of chemistry, as vice president of drug discovery.

The position suits McDonald. “I’ve been on both sides of the fence,” he says, citing 16 years of experience in big pharma and eight years in biotech. His experience in narrowing drug leads and in converting them to clinical candidates could be just what the SBI team needs. “They’re all really good scientists,” McDonald says of his department, “but with few exceptions they haven’t had experience in drug discovery.”

That’s no surprise for a firm that made its name in informatics. Thanks to SBI’s computational tools, the company has a number of leads, but McDonald will have some steering to do. “To build real value into these discoveries,” he says, the company must “take these fairly weak leads and get them down to the much more potent drug leads.”

McDonald says SBI’s computer background will only aid his cause. “We’re going to do a lot of the structural optimization with the help of computers. That generally hasn’t been done anywhere else.”

— Meredith Salisbury

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.